Cite
Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies (vol 15, 126, 2020)
MLA
Opladen T, et al. Consensus Guideline for the Diagnosis and Treatment of Tetrahydrobiopterin (BH4) Deficiencies (Vol 15, 126, 2020). Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....b3f17d3d587b21ee1a5469d761aa1f70&authtype=sso&custid=ns315887.
APA
Opladen T, López-Laso E, Cortés-Saladelafont E, Pearson TS, Sivri HS, Yildiz Y, Assmann B, Kurian MA, Leuzzi V, Heales S, Pope S, Porta F, Garcia-Cazorla A, Honzík T, Pons R, Regal L, Goez H, Artuch-Iriberri R, Hoffmann GF, … International Working Group on Neurotransmitter related Disorders (iNTD). (2020). Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies (vol 15, 126, 2020).
Chicago
Opladen T, López-Laso E, Cortés-Saladelafont E, Pearson TS, Sivri HS, Yildiz Y, Assmann B, et al. 2020. “Consensus Guideline for the Diagnosis and Treatment of Tetrahydrobiopterin (BH4) Deficiencies (Vol 15, 126, 2020),” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.RECOLECTA.....b3f17d3d587b21ee1a5469d761aa1f70&authtype=sso&custid=ns315887.